Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Karen, Osborne"'
Autor:
Marwan Ghosn, Anna Wrona, Gloria Borra, Keunchil Park, Yvonne Y. Lau, Richard Yu, Alastair Greystoke, Karen Osborne, Sang We Kim, Vanessa Q. Passos, Evaristo Maiello, Byoung Chul Cho, Wen Gu, Jeffrey W. Scott, Dong Wan Kim, Alessandra Bearz, Scott A. Laurie, Mark J. McKeage, Andrea Ardizzoni
Publikováno v:
Journal of Thoracic Oncology. 12:1357-1367
Introduction Ceritinib, 750 mg fasted, is approved for treatment of patients with ALK receptor tyrosine kinase gene (ALK)-rearranged (ALK-positive) NSCLC previously treated with crizotinib. Part 1 of the ASCEND-8 study determined whether administerin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cb292fca972eaa143dcd634099e2ba3
https://doi.org/10.1016/j.jtho.2017.07.005
https://doi.org/10.1016/j.jtho.2017.07.005
Autor:
Heather, Bracken-Grissom, Allen G, Collins, Timothy, Collins, Keith, Crandall, Daniel, Distel, Casey, Dunn, Gonzalo, Giribet, Steven, Haddock, Nancy, Knowlton, Mark, Martindale, Mónica, Medina, Charles, Messing, Stephen J, O'Brien, Gustav, Paulay, Nicolas, Putnam, Timothy, Ravasi, Greg W, Rouse, Joseph F, Ryan, Anja, Schulze, Gert, Wörheide, Maja, Adamska, Xavier, Bailly, Jesse, Breinholt, William E, Browne, M Christina, Diaz, Nathaniel, Evans, Jean-François, Flot, Nicole, Fogarty, Matthew, Johnston, Bishoy, Kamel, Akito Y, Kawahara, Tammy, Laberge, Dennis, Lavrov, François, Michonneau, Leonid L, Moroz, Todd, Oakley, Karen, Osborne, Shirley A, Pomponi, Adelaide, Rhodes, Scott R, Santos, Nori, Satoh, Robert W, Thacker, Yves, Van de Peer, Christian R, Voolstra, David Mark, Welch, Judith, Winston, Xin, Zhou
Publikováno v:
Journal of Heredity. 105:1-18
Over 95% of all metazoan (animal) species comprise the “invertebrates,” but very few genomes from these organisms have been sequenced. We have, therefore, formed a “Global Invertebrate Genomics Alliance” (GIGA). Our intent is to build a colla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9ffe6b5fbeb265547d5dcf17d9b12d
https://doi.org/10.1093/jhered/est084
https://doi.org/10.1093/jhered/est084
Autor:
Saffina DESFORGES, Karen OSBORNE
International best-selling author SAFFINA DESFORGES (writing as STEVIE JORDAN) & the creator of the wonderfully dark and disturbing,'Birdy'KAREN OSBORNE bring you...INDIGO KIDS: Seven special children - one mission. Through time and space, a group of
Autor:
S.-B. Kim, Byoung Chul Cho, D. Kim, Rafal Dziadziuszko, Radka Obermannova, Anna Cecilia Bettini, Pieter E. Postmus, Zhe Chen, Scott A. Laurie, K. Park, Alessandra Bearz, Vanessa Q. Passos, Gloria Borra, Sarayut Lucien Geater, Karen Osborne, Sergey Orlov
Publikováno v:
Journal of Thoracic Oncology. 12:S1757
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5c0ef3c0be06ebf6311e66a36230bf6
https://doi.org/10.1016/j.jtho.2017.09.352
https://doi.org/10.1016/j.jtho.2017.09.352
Autor:
Karen, Osborne, Robert, Osborne
Publikováno v:
AHP journal.
In March 2003 The Chronicle for Philanthropy reported a sea change in fund development. After 25 years of consistent research on donor motivation, a study came out with new information. Donors ranked on a scale of 1-10 what mattered most to them when
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::869d1b2b72ef43f053b40bd0ba78f79a
https://pubmed.ncbi.nlm.nih.gov/15989213
https://pubmed.ncbi.nlm.nih.gov/15989213
Autor:
Tetiana Taran, Hugues Bourgeois, Daniel Heng, Gabriel N. Hortobagyi, José Baselga, Tarek Sahmoud, Karen Osborne, Vichien Srimuninnimit, Shaker R. Dakhil, Howard A. Burris, Shinzaburo Noguchi, Mario Campone, Tibor Csoszi, Ashok Panneerselvam, Antonio Gonzalez Martin, Yoshinori Ito, Puttisak Puttawibul, Kathleen I. Pritchard, Hope S. Rugo, Martine Piccart, Michael Gnant
Publikováno v:
Clinical breast cancer, 13 (6
Background Postmenopausal women with hormone receptor-positive (HR +) breast cancer in whom disease progresses or there is recurrence while taking a nonsteroidal aromatase inhibitor (NSAI) are usually treated with exemestane (EXE), but no single stan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d8237a5ee0bb8fb0941ed28131e2690
https://doi.org/10.1016/j.clbc.2013.08.011
https://doi.org/10.1016/j.clbc.2013.08.011
Autor:
Tibor Csoszi, Shaker R. Dakhil, Michael Gnant, Tarek Sahmoud, Hugues Bourgeois, José Baselga, Hope S. Rugo, Howard A. Burris, Shinzaburo Noguchi, Karen Osborne, Martine Piccart-Gebhart, Antonio González-Martín, Pabak Mukhopadhyay, Gabriel N. Hortobagyi, Tanya Taran, Daniel Y.C. Heng, Mario Campone, Kathleen I. Pritchard, Vichien Srimuninnimit, Puttisak Puttawibul
Publikováno v:
Journal of Clinical Oncology. 30:104-104
104 Background: Postmenopausal women with estrogen-receptor–positive (ER+) BC who relapse/progress on a nonsteroidal aromatase inhibitor (NSAI) are usually treated with the steroidal AI exemestane (EXE), but there is no currently approved treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::999711fee55078301efd6054cc1eeb21
https://doi.org/10.1200/jco.2012.30.27_suppl.104
https://doi.org/10.1200/jco.2012.30.27_suppl.104
Autor:
Tarek Sahmoud, Martine Piccart-Gebhart, Howard A. Burris, Vichien Srimuninnimit, Gabriel N. Hortobagyi, Shinzaburo Noguchi, José Baselga, Karen Osborne, Puttisak Puttawibul, Hope S. Rugo, Mario Campone, Shaker R. Dakhil, Tanya Taran, Kathleen I. Pritchard, Pabak Mukhopadhyay, Michael Gnant
Publikováno v:
Journal of Clinical Oncology. 30:551-551
551 Background: Postmenopausal women with estrogen-receptor–positive (ER+) BC who relapse/progress on a nonsteroidal aromatase inhibitor (NSAI) are usually treated with the steroidal AI exemestane (EXE); but there is no currently approved treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b73cae7634719b6d6961fbf059c9a613
https://doi.org/10.1200/jco.2012.30.15_suppl.551
https://doi.org/10.1200/jco.2012.30.15_suppl.551